|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Rumgay H, Arnold M, Ferlay J, Lesi O,
Cabasag CJ, Vignat J, Laversanne M, McGlynn KA and Soerjomataram I:
Global burden of primary liver cancer in 2020 and predictions to
2040. J Hepatol. 77:1598–606. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hwang SY, Danpanichkul P, Agopian V, Mehta
N, Parikh ND, Abou-Alfa GK, Singal AG and Yang JD: Hepatocellular
carcinoma: Updates on epidemiology, surveillance, diagnosis and
treatment. Clin Mol Hepatol. 31(Suppl): S228–S254. 2025. View Article : Google Scholar :
|
|
4
|
Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH,
Chow PK and Ngeow J: Global epidemiology and genetics of
hepatocellular carcinoma. Gastroenterology. 164:766–782. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anwanwan D, Singh SK, Singh S, Saikam V
and Singh R: Challenges in liver cancer and possible treatment
approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020.
View Article : Google Scholar
|
|
6
|
Galicia-Moreno M, Silva-Gomez JA,
Lucano-Landeros S, Santos A, Monroy-Ramirez HC and
Armendariz-Borunda J: Liver cancer: Therapeutic challenges and the
importance of experimental models. Can J Gastroenterol Hepatol.
2021:88378112021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang J, Wen J, Huang Z, Chen XP, Zhang BX
and Chu L: Small nucleolar RNAs: Insight into their function in
cancer. Front Oncol. 9:5872019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pecoraro A, Pagano M, Russo G and Russo A:
Ribosome biogenesis and cancer: Overview on ribosomal proteins. Int
J Mol Sci. 22:54962021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gaviraghi M, Vivori C and Tonon G: How
cancer exploits ribosomal RNA biogenesis: A journey beyond the
boundaries of rRNA transcription. Cells. 8:10982019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elhamamsy AR, Metge BJ, Alsheikh HA,
Shevde LA and Samant RS: Ribosome biogenesis: A central player in
cancer metastasis and therapeutic resistance. Cancer Res.
82:2344–2353. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lorenzo HK: Small nucleolar RNAs as
emerging players in cancer biology and precision medicine. Cancers
(Basel). 17:38472025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gee HE, Buffa FM, Camps C, Ramachandran A,
Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, et al: The
small-nucleolar RNAs commonly used for microRNA normalisation
correlate with tumour pathology and prognosis. Br J Cancer.
104:1168–1177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blenkiron C, Hurley DG, Fitzgerald S,
Print CG and Lasham A: Links between the oncoprotein YB-1 and small
non-coding RNAs in breast cancer. PLoS One. 8:e801712013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Li Y, Li L, Liu J, Wu M and Ye M:
SnoRNAs are involved in the progression of ulcerative colitis and
colorectal cancer. Dig Liver Dis. 49:545–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshida K, Toden S, Weng W, Shigeyasu K,
Miyoshi J, Turner J, Nagasaka T, Ma Y, Takayama T, Fujiwara T and
Goel A: SNORA21-an oncogenic small nucleolar RNA, with a prognostic
biomarker potential in human colorectal cancer. EBioMedicine.
22:68–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu L, Zheng J, Chen P, Liu Q and Yuan Y:
Small nucleolar RNA ACA11 promotes proliferation, migration and
invasion in hepatocellular carcinoma by targeting the PI3K/AKT
signaling pathway. Biomed Pharmacother. 90:705–712. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li G, He Y, Liu X, Zheng Z, Zhang M, Qin F
and Lan X: Small nucleolar RNA 47 promotes tumorigenesis by
regulating EMT markers in hepatocellular carcinoma. Minerva Med.
108:396–404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui L, Nakano K, Obchoei S, Setoguchi K,
Matsumoto M, Yamamoto T, Obika S, Shimada K and Hiraoka N: Small
nucleolar noncoding RNA SNORA23, up-regulated in human pancreatic
ductal adenocarcinoma, regulates expression of spectrin
repeat-containing nuclear envelope 2 to promote growth and
metastasis of xenograft tumors in mice. Gastroenterology.
153:292–306.e2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clerget G, Bourguignon-Igel V,
Marmier-Gourrier N, Rolland N, Wacheul L, Manival X, Charron C,
Kufel J, Méreau A, Senty-Ségault V, et al: Synergistic defects in
pre-rRNA processing from mutations in the U3-specific protein Rrp9
and U3 snoRNA. Nucleic Acids Res. 48:3848–3868. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ojha S, Malla S and Lyons SM: snoRNPs:
Functions in ribosome biogenesis. Biomolecules. 10:7832020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beltrame M and Tollervey D: Base pairing
between U3 and the pre-ribosomal RNA is required for 18S rRNA
synthesis. EMBO J. 14:4350–4356. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Yu H, Yao W, Zhu N, Miao R, Liu
Z, Song X, Xue C, Cai C, Cheng M, et al: RRP9 promotes gemcitabine
resistance in pancreatic cancer via activating AKT signaling
pathway. Cell Commun Signal. 20:1882022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huan J, Liu X, Wang N, Mu Y, Li L and Du
Y: The RRP9-JUN axis promotes breast cancer progression via the AKT
signalling pathway. Biol Direct. 19:1312024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Chi X, Yang N, Shan M, Xiao Y,
Zhang M, Hao Y, Hou S, Liu Y and Wang Y: Joint effect of RRP9 and
DDX21 on development of colorectal cancer and keloid. Aging (Albany
NY). 15:14703–14719. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin J, Sun X, Ma Y, Cheng Y, Ma Q, Jing W,
Qu S and Liu L: Design, synthesis and biological evaluation of
novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment
of triple negative breast cancer by suppressing PI3K/AKT/mTOR
pathway. Bioorg Med Chem. 55:1165942022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
An Y, Cao C, Sun S, Wu H, Zhang J, Li R
and Zhao Y: SHP1 and its downstream p38/SP1/PI3K/YAP/Notch-1
signaling in trophoblast cells suppressed the progression of
Preeclampsia via inhibiting proliferation of SMCs. Sci Rep.
15:162052025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
'personalized' approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI
|
|
28
|
Reig M, Forner A, Rimola J, Ferrer-Fàbrega
J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V,
Salem R, et al: BCLC strategy for prognosis prediction and
treatment recommendation: The 2022 update. J Hepatol. 76:681–693.
2022. View Article : Google Scholar
|
|
29
|
Liu T, Shi Q, Yang L, Wang S, Song H, Wang
Z, Xu X, Liu H, Zheng H and Shen Z: Long non-coding RNAs HERH-1 and
HERH-4 facilitate cyclin A2 expression and accelerate cell cycle
progression in advanced hepatocellular carcinoma. BMC Cancer.
21:9572021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gan Y, Li Y, Li T, Shu G and Yin G: CCNA2
acts as a novel biomarker in regulating the growth and apoptosis of
colorectal cancer. Cancer Manag Res. 10:5113–5124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suski JM, Braun M, Strmiska V and Sicinski
P: Targeting cell-cycle machinery in cancer. Cancer Cell.
39:759–778. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Llovet JM, Kelley RK, Villanueva A, Singal
AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and
Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
34
|
Zhang J, Hu Z, Horta CA and Yang J:
Regulation of epithelial-mesenchymal transition by tumor
microenvironmental signals and its implication in cancer
therapeutics. Semin Cancer Biol. 88:46–66. 2023. View Article : Google Scholar :
|
|
35
|
Morana O, Wood W and Gregory CD: The
apoptosis paradox in cancer. Int J Mol Sci. 23:13282022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ding Y, Sun Z, Zhang S, Zhou L, Xu Q, Zhou
D, Li Y, Han X, Xu H, Bai Y, et al: Identification of snoRNA
SNORA71A as a novel biomarker in prognosis of hepatocellular
carcinoma. Dis Markers. 2020:88799442020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Z, Tao Y, Hua Q, Cai J, Ye X and Li
H: SNORA71A promotes colorectal cancer cell proliferation,
migration, and invasion. Biomed Res Int. 2020:82845762020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dragon F, Gallagher JE, Compagnone-Post
PA, Mitchell BM, Porwancher KA, Wehner KA, Wormsley S, Settlage RE,
Shabanowitz J, Osheim Y, et al: A large nucleolar U3
ribonucleoprotein required for 18S ribosomal RNA biogenesis.
Nature. 417:967–970. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chi X, Yang N and Liu Y: RRP9 and DDX21 as
new biomarkers of colorectal cancer. Medicine (Baltimore).
102:e343842023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li N, Jing Y, Xu L and Wang M: METTL1
enhances RRP9 mRNA stability through m7G modification to drive
colorectal tumorigenesis. Mol Carcinog. 64:858–869. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alzahrani AS: PI3K/Akt/mTOR inhibitors in
cancer: At the bench and bedside. Semin Cancer Biol. 59:125–132.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Liu Z, Yan H, Zhou T, Zheng L, Wen
F, Guo G and Zhang Z: Polygonatum sibiricum polysaccharide
ameliorates skeletal muscle aging and mitochondrial dysfunction via
PI3K/Akt/mTOR signaling pathway. Phytomedicine. 136:1563162025.
View Article : Google Scholar
|
|
43
|
Chen J, Chen J, Huang J, Li Z, Gong Y, Zou
B, Liu X, Ding L, Li P, Zhu Z, et al: HIF-2α upregulation mediated
by hypoxia promotes NAFLD-HCC progression by activating lipid
synthesis via the PI3K-AKT-mTOR pathway. Aging (Albany NY).
11:10839–10860. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang J, Pi C and Wang G: Inhibition of
PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy
in hepatocellular carcinoma cells. Biomed Pharmacother.
103:699–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Du MG, Liu F, Chang Y, Tong S, Liu W, Chen
YJ and Xie P: Neddylation modification of the U3 snoRNA-binding
protein RRP9 by Smurf1 promotes tumorigenesis. J Biol Chem.
297:1013072021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen S, Blank MF, Iyer A, Huang B, Wang L,
Grummt I and Voit R: SIRT7-dependent deacetylation of the U3-55k
protein controls pre-rRNA processing. Nat Commun. 7:107342016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Modenini G, Abondio P and Boattini A: The
coevolution between APOBEC3 and retrotransposons in primates. Mob
DNA. 13:272022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen X, Wang X, Zhu F, Qian C, Xu F, Huang
X, Zhang W and Sun B: HBV infection-related PDZK1 plays an
oncogenic role by regulating the PI3K-Akt pathway and fatty acid
metabolism and enhances immunosuppression. J Immunol Res.
2022:87855672022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qu H, Xie Y, Hu S, Sun S, Yuan Y, Xia Y,
Liu M and Zhang XL: HBV upregulates TNNT1 expression through
PI3K/AKT/mTOR-c-Myc axis, which in turn induces EMT and liver
fibrosis in mice. Cell Signal. 134:1118992025. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hussain MS, Moglad E, Afzal M, Gupta G,
Hassan Almalki W, Kazmi I, Alzarea SI, Kukreti N, Gupta S, Kumar D,
et al: Non-coding RNA mediated regulation of PI3K/Akt pathway in
hepatocellular carcinoma: Therapeutic perspectives. Pathol Res
Pract. 258:1553032024. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zacchini F, Barozzi C, Venturi G and
Montanaro L: How snoRNAs can contribute to cancer at multiple
levels. NAR Cancer. 6:zcae0052024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Z, Zhao C, Li M, Zhang L, Diao J, Wu
Y, Yang T, Shi M, Lei Y, Wang Y, et al: Tuina therapy alleviates
knee osteoarthritis by modulating PI3K/AKT/mTOR-mediated autophagy:
An integrated machine learning and in vivo rat study. Front
Immunol. 16:16358182025. View Article : Google Scholar : PubMed/NCBI
|
